Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-15, Stock:ABBV, The news for the past five days is as follows:
2019-03-08: NEWS1: The Kiplinger Dividend 15 Is On a Roll.NEWS2: The Kiplinger Dividend 15 Is On a Roll.NEWS3: Don’t Abandon Gilead Stock After Weak Q4 Results.NEWS4: Don’t Abandon Gilead Stock After Weak Q4 Results.NEWS5: Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs.NEWS6: Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC.NEWS7: Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC.NEWS8: Don’t Abandon Gilead Stock After Weak Q4 Results.NEWS9: Roche's (RHHBY) Tecentriq Gets EC Nod for First-Line NSCLC.
2019-03-11: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: Should Value Investors Consider Abbvie (ABBV) Stock Now?.NEWS3: Should Value Investors Consider Abbvie (ABBV) Stock Now?.NEWS4: Should Value Investors Consider Abbvie (ABBV) Stock Now?.
2019-03-12: NEWS1: Takeda's Entyvio Tops AbbVie's Humira in Patients With Ulcerative Colitis.NEWS2: Noteworthy Tuesday Option Activity: AMG, NRG, ABBV.NEWS3: Noteworthy Tuesday Option Activity: AMG, NRG, ABBV.NEWS4: Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval.NEWS5: Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval.NEWS6: Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval.NEWS7: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS8: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS9: AbbVie (ABBV) Gains But Lags Market: What You Should Know.
2019-03-13: NEWS1: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS2: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS3: Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study.NEWS4: FDA medical adviser: 'Congress is owned by pharma'.
2019-03-14: NEWS1: Roche Receives EC Approval for Label Expansion of Hemlibra.NEWS2: Roche Receives EC Approval for Label Expansion of Hemlibra.NEWS3: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS4: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS5: Roche Receives EC Approval for Label Expansion of Hemlibra.NEWS6: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS7: The Timely Ten- Blue Chip Buys with Value and Yield.NEWS8: Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades.

Answer: Rise